BRCA testing in India costs between ₹3,000 and ₹25,000 depending on the type of test — from a targeted mutation analysis to a comprehensive hereditary cancer panel. This guide explains who should get tested, which test is right for you, and how to interpret your results with a genetic counselor.

What Are BRCA1 and BRCA2?

BRCA1 and BRCA2 are tumour-suppressor genes whose normal function is to repair damaged DNA and prevent cells from growing uncontrollably. When a person carries a pathogenic mutation in BRCA1 or BRCA2, this repair mechanism is impaired — significantly increasing the risk of breast, ovarian, and several other cancers.

Mutations in these genes are hereditary, meaning they are passed down through families. Each child of a BRCA mutation carrier has a 50% chance of inheriting the mutation. BRCA mutations are the most common cause of hereditary breast and ovarian cancer (HBOC) syndrome.

Cancer TypeBRCA1 Lifetime RiskBRCA2 Lifetime RiskGeneral Population Risk
Breast cancer (female)50–72%40–69%~12%
Ovarian cancer44–46%17–23%~1.3%
Breast cancer (male)~1–2%~6–8%~0.1%
Pancreatic cancerSlightly elevated~3–5%~1.6%

BRCA Testing Costs in India

Test TypeWhat It TestsCost Range (INR)Best For
Targeted BRCA mutation testSpecific known mutation in family₹3,000 – ₹5,000Family members of a known BRCA carrier
Full BRCA1/BRCA2 sequencingAll mutations in BRCA1 and BRCA2₹8,000 – ₹15,000No known family mutation; strong personal/family history
Hereditary cancer panelBRCA1, BRCA2 + 20–80 other cancer genes₹18,000 – ₹25,000Multiple cancer types in family; comprehensive risk assessment
Government / subsidizedVaries₹2,000 – ₹6,000AIIMS, regional cancer centres, Ayushman Bharat empanelled labs

Cost tip: If a specific BRCA mutation has already been identified in a close relative, your test is a simple targeted analysis — costing ₹3,000–₹5,000 rather than ₹8,000–₹15,000 for full sequencing. Always confirm whether a family mutation is already known before ordering.

Who Should Get BRCA Testing?

BRCA Testing Is Recommended If You Have
  • Personal history of breast cancer diagnosed before age 50
  • Personal history of triple-negative breast cancer at any age
  • Personal history of ovarian, fallopian tube, or primary peritoneal cancer
  • Male breast cancer
  • Two or more close relatives (mother, sister, daughter, father, brother) with breast or ovarian cancer
  • A relative with bilateral breast cancer or both breast and ovarian cancer
  • Ashkenazi Jewish ancestry with any breast or ovarian cancer in the family
  • A known BRCA mutation in a close blood relative

Which BRCA Test Should You Choose?

Option 1: Targeted Single-Mutation Test

If a specific BRCA1 or BRCA2 mutation has already been identified in your family, only that mutation needs to be tested. This is the most cost-effective approach (₹3,000–₹5,000) and gives a clear positive or negative result.

Option 2: Full BRCA1/BRCA2 Sequencing

If no family mutation is known but personal or family history is significant, full sequencing of both genes is recommended (₹8,000–₹15,000). This detects all types of mutations across the entire BRCA1 and BRCA2 genes.

Option 3: Hereditary Cancer Panel

If family history includes multiple cancer types or if full BRCA sequencing returns negative with a strong clinical picture, a multi-gene panel (₹18,000–₹25,000) tests BRCA1, BRCA2, plus PALB2, ATM, CHEK2, CDH1, PTEN, STK11, RAD51C, RAD51D, and other relevant genes simultaneously.

After Your BRCA Test: What Happens Next

Positive Result

Personalised surveillance plan (MRI + mammogram annually), discussion of risk-reduction surgery (mastectomy, salpingo-oophorectomy), and cascade family testing.

Negative Result (Full Sequencing)

Does not eliminate all hereditary risk. If family history remains strong, a broader panel may be recommended. Standard population screening applies.

⚠️
Variant of Uncertain Significance

A DNA change found but not enough evidence to classify. Family testing may help reclassify. Periodic re-evaluation as more data emerges.

👨‍👩‍👧
Family Testing

Once your mutation is known, each first-degree relative can be tested with a targeted test (₹3,000–₹5,000) for the same mutation.

How to Get BRCA Testing in India

  1. Consult a genetic counselor — they review your personal and family history to determine the right test and lab, and explain what results will mean for you and your family before you test.
  2. Order the test — the genetic counselor provides a test requisition form; a blood sample (~5 ml) is collected at a nearby collection centre or at home.
  3. Receive the report — typically 2–4 weeks; full sequencing or panels may take 4–6 weeks.
  4. Post-test counseling — a genetic counselor interprets the report, explains risk numbers, and coordinates next steps (surveillance, family testing, referrals).

Book a BRCA Genetic Counseling Session

Lakshita Thakore is a BGCI Certified Genetic Counselor. She will review your family history, recommend the right test, and guide you through your results.

Book Consultation

Frequently Asked Questions

BRCA testing costs in India range from ₹3,000 to ₹25,000 depending on the type. A targeted single-mutation test costs ₹3,000–₹5,000. Full BRCA1/BRCA2 gene sequencing costs ₹8,000–₹15,000. A comprehensive hereditary cancer panel (BRCA1, BRCA2 + 20–80 other genes) costs ₹18,000–₹25,000. Government hospitals may offer subsidized rates of ₹2,000–₹6,000.
BRCA testing is recommended if you have a personal history of breast cancer before age 50, triple-negative breast cancer, ovarian cancer, male breast cancer, two or more close relatives with breast or ovarian cancer, Ashkenazi Jewish ancestry with any breast/ovarian cancer in the family, or a known BRCA mutation in a close relative. A genetic counselor can assess your history to determine if testing is appropriate.
A BRCA test specifically sequences BRCA1 and BRCA2 genes. A hereditary cancer panel tests 20–80 genes associated with multiple cancer types simultaneously. Panels are recommended when family history suggests multiple cancer types, or when BRCA alone does not explain the family history.
A positive BRCA1 or BRCA2 result means you carry a mutation that significantly increases your cancer risk. BRCA1 carriers have a 50–72% lifetime breast cancer risk and 44% ovarian cancer risk. BRCA2 carriers have a 40–69% breast cancer risk and 17–23% ovarian cancer risk. A positive result does not mean you will definitely develop cancer — it means you need a personalised surveillance and risk-reduction plan with an oncologist and genetic counselor.
No. A negative BRCA1/BRCA2 test does not rule out hereditary breast cancer. About 25–30% of hereditary breast cancer cases involve other genes (PALB2, ATM, CHEK2, CDH1, etc.). If your personal or family history is strong, your genetic counselor may recommend a broader hereditary cancer panel even after a negative BRCA result.
Yes. Each first-degree relative (parent, sibling, child) of a BRCA-positive individual has a 50% chance of carrying the same mutation. Once your specific mutation is identified, family members can be tested with a simple targeted test for ₹3,000–₹5,000 — much less than full sequencing. Those who test negative can follow general population guidelines.
Coverage varies widely by insurer and policy. Most standard policies do not cover genetic testing unless specifically included. Some women's health or oncology riders may cover it when ordered by an oncologist with documented medical necessity. Government schemes like Ayushman Bharat may cover testing at empanelled centers for qualifying conditions. Always check your policy and get prior authorization if possible.